1Ferreri A J,Abrey L E,Blay J Y,et al.Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma,Lugano Switzerland,June 12-15,2002.J Clin Oncol,2003,21:2407-2414.
2Nakamura M,Shimada K,Ishida E,et al.Histopathology,pathogenesis and molecular genetics in primary central nervous system lymphomas.Histol Histopathol,2004,19:211-219.
3Deangellis LM.Primary central nervous system lymphoma:treatment with combined chemotherapy and radiotherapy.J Neurooncol,1999,43:249-257.
5Ferreri AJ,Blay JY,Reni M,et al.Prognostic scoring system for primary CNS lymphomas:the International Extranodal Lymphoma Study Group experience.J Clin Oncol,2003,21:266-272.
6Kraemer DE,Fortin D,Doolittle ND,et al.Association of total dose intensity of chemotherapy in primary central nervous system lymphlma and survival.Neurosurg,2001,48:1033-1041.
7Mcallister LD,Doolittle ND,Guastadisegni PE,et al.Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma.Neurosurgery,2000,46:51-61.
8Reni M,Gruber ML,Cher L,et al.Preirradiation methotrexate chemotherapy of primary malignant non-Hodgkin' s lymphoma of the central nrvous system:Preliminary data.Ann Oncol,1997,8:227-234.
9Brecher K, Hechberg FH, Louis DN, et al. Case report of unusual laukoencephalopathy preceding primary CNS lymphoma. J Neurol Neurosurg Psychiatry, 1998, 65(6): 917-920.
10Herrlinger U, Schabet M, Clemens M, et al. Clinical presentation and therapeutic outcome in 26 patients with primary CNS lymphoma. Acta Neurol Scand, 1998, 97(4): 257-264.
